Echosens Introduces FibroScan 630 Expert: Adds New Spleen Stiffness Measurement (SSM by VCTE™) for Risk Stratification of Patients with Advanced Chronic Liver Disease Waltham, MA – November 9, 2020 – Echosens,…
Read More
Echosens recognizes November 2-6, 2020 as Obesity Week and the dedicated professionals at the Obesity Society who are collaborating to overcome obesity. During this week, Echosens points to the link…
Join us in supporting October 2020 Liver Cancer Awareness Month In the spirit of Liver Cancer Awareness Month this October, Echosens would like to highlight some alarming trends to help…
Self-Insured Employers Can Boost Workforce Productivity, Reduce Medical Costs Download our latest white paper: “Comprehensive Chronic Care Disease Management of Liver Disease Improves Member Outcomes, Reduces Costs for Employer-…
NASH Network (NASHNET), a global network of thought leaders dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), has published a novel cost-effectiveness analysis…
The impact of the obesity epidemic in America is reflected in increasing rates of Type 2 diabetes, nonalcoholic fatty liver disease (NAFLD), as well as poorer outcomes with the COVID-19…
Join us in celebrating National Health Center Week, August 9-15, 2020! Community Health Center Physicians Utilizing Rapid, Non-Invasive Exam to Identify and Monitor People Living with “Silent” Liver Disease In…
This June 12, 2020, on International NASH Day, Echosens joins healthcare leaders to increase awareness about non-alcoholic steatohepatitis (NASH) among the general public, at-risk patients, the medical community, public health…
Underscore Need for Early Detection Many of us are familiar with liver disease caused by excessive alcohol intake, but with the increasing rates of Type 2 diabetes and obesity, non-alcoholic…
May is Hepatitis Awareness Month and Echosens is calling for increased vigilance and attention to the millions of Americans from all walks of life who are living with the most common causes of viral hepatitis: hepatitis B virus (HBV) and hepatitis C virus (HCV). People with chronic HBV may be at significantly increased risk of disease progression due to non-alcoholic fatty liver disease (NAFLD), which affects 1:3 Americans.
